Compumedics eyes $70M FY26 target ahead of US pivot – and a potential $1B US IPO

Welcome to the latest HotCopper Capital Compass, where we’ve this week spoken to Compumedics Ltd (ASX:CMP) founder and CEO David Burton to discuss the company’s history, its work developing technologies in the sleep neurology and brain imaging space, and what lies ahead in CY26.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

Disclaimer: This content has been prepared as part of an ongoing partnership with Compumedics Ltd and is intended for informational purposes only.

“Back in ’87, the company really culminated on the development of a computerised relief centre, which was the first in the Asia-Pacific region… the problem was that we needed to bring greater access for health care in sleep to more people, vs. a boutique research function,” Mr Burton told The Market Link.

He added: “Pretty soon it was on the front cover of Time, quite widely advertised, and thereafter we had growing demand for sleep systems.”

Now, in FY26, it has grand U.S. plans again — and is even looking into a $1 billion IPO that will take it into Wall Street’s mega trading markets.

For a full overview on CMP, you can watch the interview in the browser above.

Join the discussion. See what HotCopper users are saying about Compumedics Ltd and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.